191 related articles for article (PubMed ID: 26581414)
1. The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram.
Tanaka N; Shimada K; Nakagawa Y; Hirao S; Watanabe S; Miyake M; Anai S; Hirayama A; Konishi N; Fujimoto K
BMC Res Notes; 2015 Nov; 8():689. PubMed ID: 26581414
[TBL] [Abstract][Full Text] [Related]
2. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
3. Length of prostate biopsy cores: does it impact cancer detection?
Fiset PO; Aprikian A; Brimo F
Can J Urol; 2013 Aug; 20(4):6848-53. PubMed ID: 23930611
[TBL] [Abstract][Full Text] [Related]
4. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
[TBL] [Abstract][Full Text] [Related]
5. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume.
Remzi M; Fong YK; Dobrovits M; Anagnostou T; Seitz C; Waldert M; Harik M; Marihart S; Marberger M; Djavan B
J Urol; 2005 Oct; 174(4 Pt 1):1256-60; discussion 1260-1; author reply 1261. PubMed ID: 16145388
[TBL] [Abstract][Full Text] [Related]
6. A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients.
Huang Y; Cheng G; Liu B; Shao P; Qin C; Li J; Hua L; Yin C
BMC Urol; 2014 Jan; 14():8. PubMed ID: 24410803
[TBL] [Abstract][Full Text] [Related]
7. Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient's age and prostate volume.
Hori S; Tanaka N; Nakai Y; Morizawa Y; Tatsumi Y; Miyake M; Anai S; Fujii T; Konishi N; Nakagawa Y; Hirao S; Fujimoto K
Res Rep Urol; 2019; 11():61-68. PubMed ID: 30937289
[TBL] [Abstract][Full Text] [Related]
8. Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
Pepe P; Pennisi M; Fraggetta F
Int Braz J Urol; 2015; 41(5):844-8. PubMed ID: 26689509
[TBL] [Abstract][Full Text] [Related]
9. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
[TBL] [Abstract][Full Text] [Related]
10. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
11. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
Tanaka N; Fujimoto K; Yoshikawa M; Tanaka M; Hirao Y; Kondo H; Saito I
Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
[TBL] [Abstract][Full Text] [Related]
12. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
Uno H; Nakano M; Ehara H; Deguchi T
Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
[TBL] [Abstract][Full Text] [Related]
13. The roles of prostate-specific antigen (PSA) density, prostate volume, and their zone-adjusted derivatives in predicting prostate cancer in patients with PSA less than 20.0 ng/mL.
Shen P; Zhao J; Sun G; Chen N; Zhang X; Gui H; Yang Y; Liu J; Shu K; Wang Z; Zeng H
Andrology; 2017 May; 5(3):548-555. PubMed ID: 28409907
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.
Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY
Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012
[TBL] [Abstract][Full Text] [Related]
15. Intermediate versus low or high prostate-specific antigen density level: comparison of cancer detection rate between 12- and 18-core prostate biopsy.
Park HK; Lee KY; Kim KH; Jung H; Yoon SJ; Kim TB
Scand J Urol Nephrol; 2010 Dec; 44(6):391-8. PubMed ID: 20695726
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Vacherot F; Vordos D; Allory Y; Abbou CC; Salomon L; de la Taille A
Eur Urol; 2014 Jan; 65(1):154-61. PubMed ID: 22698576
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Clin Oncol; 2004 Feb; 9(1):47-50. PubMed ID: 15162826
[TBL] [Abstract][Full Text] [Related]
18. How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
Aglamis E; Kocaarslan R; Yucetas U; Toktas G; Ceylan C; Doluoglu OG; Unluer E
Int Braz J Urol; 2014; 40(5):605-12. PubMed ID: 25498271
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison of the Montreal nomogram with the detection of primary malignant circulating prostate cells to predict prostate cancer at initial biopsy in Chilean men with suspicion of prostate cancer.
Murray NP; Reyes E; Fuentealba C; Orellana N; Jacob O; Badilla S
Urol Oncol; 2015 May; 33(5):203.e19-25. PubMed ID: 25746939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
